Victrex (LON:VCT)‘s stock had its “underperform” rating reiterated by BNP Paribas in a research note issued to investors on Thursday.
Several other equities research analysts have also commented on the stock. Berenberg Bank boosted their price objective on shares of Victrex from GBX 1,320 ($18.53) to GBX 1,380 ($19.37) and gave the stock a “buy” rating in a research report on Friday, February 23rd. Liberum Capital reiterated a “buy” rating and issued a GBX 2,770 ($38.88) price objective on shares of Victrex in a research report on Tuesday, January 30th. Numis Securities reiterated a “hold” rating and issued a GBX 2,550 ($35.79) price objective (up from GBX 2,300 ($32.29)) on shares of Victrex in a research report on Monday, February 12th. JPMorgan Chase boosted their price objective on shares of Victrex from GBX 2,250 ($31.58) to GBX 2,580 ($36.22) and gave the stock a “neutral” rating in a research report on Monday, January 8th. Finally, Peel Hunt reiterated a “hold” rating and issued a GBX 2,400 ($33.69) price objective on shares of Victrex in a research report on Monday, February 12th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and three have given a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and a consensus price target of GBX 2,297.09 ($32.24).
Victrex stock opened at GBX 2,564 ($35.99) on Thursday. Victrex has a 52 week low of GBX 1,826 ($25.63) and a 52 week high of GBX 2,772 ($38.91).
COPYRIGHT VIOLATION WARNING: This news story was originally published by Ticker Report and is the sole property of of Ticker Report. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright law. The original version of this news story can be read at https://www.tickerreport.com/banking-finance/3337250/victrex-vct-rating-reiterated-by-bnp-paribas.html.
Victrex plc is a United Kingdom-based holding company. The Company is engaged in the manufacture and sale of various polymers. The Company’s operating segments include Industrial (Victrex Polymer Solutions) and Medical (Invibio Biomaterial Solutions). The Victrex Polymer Solutions segment focuses on automotive, aerospace, electronics and energy markets.
Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.